Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.

@article{Wang2010PrognosticVO,
  title={Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer.},
  author={Xin Shelley Wang and Qiuling Shi and Charles Lu and Ethan M. Basch and V. E. Johnson and Tito R Mendoza and Gary M Mobley and Charles S. Cleeland},
  journal={Cancer},
  year={2010},
  volume={116 1},
  pages={137-45}
}
BACKGROUND Patient-reported outcomes have shown independent prognostic value for patients with nonsmall cell lung cancer (NSCLC). However, translating patient-reported outcomes into useful prognostic information for individual patients has been problematic. METHODS A total of 94 patients with advanced NSCLC and an Eastern Cooperative Oncology Group performance status (PS) of 0 to 2 who qualified for chemotherapy rated symptom severity using the M. D. Anderson Symptom Inventory before and… CONTINUE READING